Mo Vaughn, a three-time All-Star first baseman and the 1995 American League Most Valuable Player Award winner, has admitted to The Athletic that he used human growth hormone in an attempt to ...

Former MLB slugger Mo Vaughn, winner of the 1995 American League MVP award while a member of the Red Sox, recently confirmed details originally reported in the 2007 Mitchell Report regarding his ...

SAN DIEGO--(BUSINESS WIRE)--Capstan Therapeutics, Inc. (“Capstan”), a biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA delivery using targeted lipid ...

Former big league slugger Mo Vaughn has confirmed he used human growth hormone to recover from a nagging knee injury late in his career. The 1995 American League MVP told The Athletic in a recent ...

SAN DIEGO & PHILADELPHIA--(BUSINESS WIRE)--Capstan Therapeutics, Inc., a biotechnology company dedicated to developing and delivering precise in vivo cell engineering to patients, launched today ...

Capstan Therapeutics has launched with $165 million for in vivo cell engineering to treat disease. The start-up’s technology is based on research from the University of Pennsylvania, with ...